Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume II.

The editorial in "Frontiers in Immunology" discusses recent advances in biomarkers for inflammatory rheumatic diseases (IRDs) and cell-based therapies. The second volume includes 3 review articles and 7 original articles focusing on biomarkers in IRDs, such as neopterin, DNA methylation, and serum proteome profiling. Studies also explore biomarkers for specific diseases like axial spondyloarthritis, psoriatic arthritis, and lupus nephritis, offering insights into diagnosis, disease activity, and treatment response. The use of laboratory analysis, statistical tools, and machine learning is highlighted as valuable in predicting and managing IRDs. [Extracted from the article]